Atlas Trials

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

Clinical trial NCT05037825 · RECRUITING

Trial details

NCT number
NCT05037825
Sponsor
VastBiome
Status
RECRUITING
Study type
OBSERVATIONAL
Non-Small-Cell Lung CarcinomaMalignant MelanomaRenal Cell CarcinomaTriple-Negative Breast Cancer
Start date
2021-11-22
Primary completion
2023-09-14
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.